Institute of Metabolic Physiology, Heinrich-Heine University, D-40225 Düsseldorf, Germany.
J Mol Cell Biol. 2012 Aug;4(4):221-30. doi: 10.1093/jmcb/mjs025. Epub 2012 May 19.
Elderly patients often suffer from multiple age-related diseases. Here we show that the expression of DJ-1, an antioxidant protein with reduced expression in the central nervous system of patients with Parkinson's disease, is reduced in pancreatic islets of patients with type 2 diabetes mellitus (T2DM). In contrast, under non-diabetic conditions, DJ-1 expression increases in mouse and human islets during aging. In mouse islets, we show that DJ-1 prevents an increase in reactive oxygen species levels as the mice age. This antioxidant function preserves mitochondrial integrity and physiology, prerequisites for glucose-stimulated insulin secretion. Accordingly, DJ-1-deficient mice develop glucose intolerance and reduced β cell area as they age or gain weight. Our data suggest that DJ-1 is more generally involved in age- and lifestyle-related human diseases and show for the first time that DJ-1 plays a key role in glucose homeostasis and might serve as a novel drug target for T2DM.
老年患者常患有多种与年龄相关的疾病。在这里,我们表明,帕金森病患者中枢神经系统中表达减少的抗氧化蛋白 DJ-1在 2 型糖尿病 (T2DM) 患者的胰岛中表达降低。相比之下,在非糖尿病条件下,DJ-1 在衰老过程中会增加小鼠和人胰岛中的表达。在小鼠胰岛中,我们表明 DJ-1 可防止随着年龄的增长,活性氧水平升高。这种抗氧化功能保持了线粒体的完整性和生理功能,这是葡萄糖刺激胰岛素分泌的前提。因此,随着年龄的增长或体重增加,缺乏 DJ-1 的小鼠会出现葡萄糖不耐受和β细胞面积减少。我们的数据表明,DJ-1 更广泛地参与与年龄和生活方式相关的人类疾病,并首次表明 DJ-1 在葡萄糖稳态中起关键作用,可能成为 T2DM 的新药物靶点。